Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab.
Paltiel M, Gober LM, Deng A, Mikdashi J, Alexeeva I, Saini SS, Gaspari AA. Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab. Arch Dermatol. 2008 Sep; 144(9):1190-4.